Clinical trials
Neurology clinical trials
Below are recruiting neurology clinical trials, each written for real people, not researchers. We’re tracking 380 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05663281Recruiting
Imaging treatment plan for blocked brain or neck arteries
This study uses special MRI “vessel wall” imaging to better understand blocked arteries in the brain or neck, confirmed on a scan. It aims to help analyze imaging findings to guide treatment decisions and reduce problems from artery blockage.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05705453Recruiting
Spinal cord stimulation study for long-term spinal injury outcomes
This study looks at how spinal cord stimulation affects long-term recovery and daily functioning in people with stable spinal cord injury. You may be eligible if you already have an implanted, FDA-approved spinal cord stimulator and meet specific safety and timing rules.
Minneapolis, MinnesotaAges 22 years+ - NCT05706831Recruiting
Music and gentle brain stimulation after neurological injury
This trial tests whether combining music with gentle electrical brain stimulation can improve symptoms after a neurologic event, such as language and attention problems. It’s meant for adults who are living with effects of stroke and certain levels of reduced awareness.
Bari, BaAges 18 years+ - NCT05766059Recruiting
Noninvasive brain stimulation to aid stroke or phantom limb pain rehab
This trial tests new, noninvasive brain stimulation techniques to help recovery after stroke weakness or after arm amputation with phantom limb pain. If you fit the type and timing of your condition, the study may help improve pain or hand/arm function without surgery.
Milan, LombardyAges 18–85 - NCT05767476Recruiting
Testing cooling treatment after lack of oxygen at birth
This trial studies outcomes in newborns who had breathing problems from low oxygen before or during birth and were treated with a cooling therapy (therapeutic hypothermia). It may help doctors understand which babies benefit most and what recovery looks like over time.
RomeAges 10 minutes–6 hours - NCT05799118Recruiting
Genetic modifiers study for inherited blood disorders
This study looks at how your genes can affect inherited blood conditions like sickle cell disease and thalassemia. It may help researchers understand why symptoms differ from person to person, which could guide better future treatments.
Boston, MassachusettsAges 2 years+ - NCT05819008Recruiting
Online brain testing for people with neurological conditions
This trial studies how well a remote, online memory and thinking assessment works for people with neurological disorders or injuries. You may be invited if you can do the computer-based testing and speak Swedish.
UmeåAges 18 years+ - NCT05820074Recruiting
Neural signals and walking changes in Parkinson’s patients
This study measures brain and nerve “biomarkers” to understand how Parkinson’s affects walking and balance. It may help researchers identify signs that relate to gait problems, and participants with a specific implanted stimulator may be able to take part in testing with stimulation turned off.
Vitznau, Canton of LucerneAges 18 years+ - NCT05826548Recruiting
Telerehabilitation program for memory, Parkinson’s, and stroke needs
This trial studies a home-based exercise and training program delivered by telerehabilitation (remote care) for people with mild cognitive impairment, Parkinson’s disease, or stroke. It may help improve day-to-day thinking and movement skills by supporting you with structured practice from home.
Lido, VeneziaAges 18–85 - NCT05839418Recruiting
Registry study for people with status epilepticus
This study records information about people who are in the hospital with status epilepticus (prolonged seizure activity) to better understand care for refractory cases. If you qualify, your team may collect your clinical details during your hospital stay rather than giving a new treatment as part of the study.
LinzAges 18 years+ - NCT05849467RecruitingPhase 1
Testing how the brain absorbs anti–CD8 therapy in nervous system disease
This Phase 1 study tests a small drug (called an anti–CD8+ T cell minibody) to see how much reaches the brain. It may help researchers understand how to deliver similar treatments for multiple sclerosis, progressive multifocal leukoencephalopathy (PML), or other brain inflammation when the brain’s protective barrier is “open.”
Bethesda, MarylandAges 18–120 - NCT05852418Recruiting
Registry study of devices, medicines, and care in ALS and SMA
This study collects information in a registry about assistive devices, medicines, and healthcare support for people with long-term neurological conditions like ALS and SMA. It may help researchers understand what treatments and supports are used and how they relate to patients’ needs over time.
BerlinAges 18 years+ - NCT05900778Recruiting
HABIT-ILE program for school-aged children after brain injury
This trial tests whether a structured HABIT-ILE program helps children with a brain injury improve daily functioning at school and during therapy sessions. It may help families build skills and routines, but it requires meeting specific health and timing criteria.
Ottignies-Louvain-la-Neuve, Brabant-WallonAges 5–18 - NCT05901259Recruiting
Tracking routine outcomes using a mobility suit database
This trial sets up a database to follow routine health and mobility outcomes over time. You may be included if you have certain neurological conditions and can safely use the EXOPULSE suit.
Bergshamra, Stockholm CountyAges 2 years+ - NCT05925621Recruiting
Registry for early Alzheimer-related memory problems
This study registry collects health and brain-testing information for people with mild cognitive impairment or early Alzheimer’s dementia. It may help researchers better understand early Alzheimer disease and plan future treatments.
Boston, MassachusettsAges 50–95 - NCT05940584Recruiting
Video rehabilitation at home vs paper aftercare after hospital rehab
This study compares home “tele-rehabilitation” (video/online exercises) with a traditional paper-based aftercare program after you leave inpatient rehabilitation. It may help improve recovery in movement, sensation, thinking, swallowing, or speech by giving the right kind of support after discharge.
Vienna, State of ViennaAges 18–99 - NCT05943652Recruiting
Study of how functional overlay affects movement disorders
This study looks at movement disorders that are functional (not caused by damage to the nervous system) or non-functional, and how a “functional overlay” may change symptoms. It is observational, meaning it does not test a new treatment, but it may help researchers better understand these differences and improve care.
Graz, StyriaAges 18–18 - NCT05961644RecruitingPhase 2/Phase 3
Cladribine vs placebo for non-active progressive multiple sclerosis
This trial tests whether cladribine (vs an inactive placebo pill) can slow disability worsening in people with a non-active, progressive form of multiple sclerosis. It may help by reducing the immune activity that can drive ongoing nerve damage, even without recent relapses.
Warsaw, Masovian VoivodeshipAges 30–65 - NCT05971329Recruiting
Pilot study of bone graft for cervical disc wear and nerve symptoms
This trial tests a new bone graft product (ZetaFuse™) used during front-of-the-neck surgery to treat “wear and tear” in the cervical (neck) discs causing nerve problems. It may help relieve pain and nerve-related symptoms when other treatments haven’t worked.
Randwick, New South WalesAges 22–75 - NCT05993390Recruiting
Reversing muscle relaxants in ICU patients
This trial tests two medicines that help reverse the muscle-relaxing drugs given to patients on breathing tubes in the intensive care unit. The goal is to see which one works better and faster so patients can wake up sooner.
Seoul, Jongno-guAges 19–90 - NCT05996211Recruiting
Swiss Study on Brain Development in Children with Heart Defects
This study follows children with severe heart problems born recently to see how their brain development progresses. It helps doctors understand what support these children might need as they grow.
BernAges 1 week–1 month - NCT06032026RecruitingEarly Phase 1
Brain imaging study of tracer distribution in Parkinson's and related conditions
This study uses a special imaging tracer to see how it moves through the body and brain. It may help researchers understand brain changes in Parkinson's disease and related conditions.
Philadelphia, PennsylvaniaAges 40–80 - NCT06033027Recruiting
Testing a soft robotic glove for hand help
This trial tests a soft robotic glove that helps you grip and hold objects if your hand is weak due to a nerve problem or injury. It's meant for people who have trouble with daily tasks like eating or dressing.
Enschede, OverijsselAges 18–90 - NCT06083467Recruiting
Brain imaging study for Parkinson's and related disorders
This study uses brain imaging and tests to better understand Parkinson's disease and related conditions. It aims to improve diagnosis by comparing scans across different groups of people.
Philadelphia, PennsylvaniaAges 40–85
Hear when a new Neurology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurology?
- Yes. Clin2 currently lists 380 recruiting neurology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.